CIA
RGEN icon

Cladis Investment Advisory’s Repligen RGEN Stock Holding History

Cladis Investment Advisory’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$265K – 157
2021
Q4 		$265K Buy
+1,000
New +$269K 0.21% 124

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cladis Investment Advisory's RGEN Position: Q1 2022 in Review

Cladis Investment Advisory sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,000 shares — an estimated $265K sold.

Cladis Investment Advisory first reported a position in RGEN in Q4 2021 and held it in 1 quarter. The position peaked at $265K in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Cladis Investment Advisory reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Cladis Investment Advisory sold 1,000 Repligen shares in Q1 2022, an estimated $265K.
  • Cladis Investment Advisory first reported a position in Repligen in Q4 2021 and held it in 1 quarter.
  • Cladis Investment Advisory's Repligen position peaked at $265K in Q4 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Cladis Investment Advisory's 13F filing for Q1 2022, filed 10 May 2022.